000538.SZ
云南白药
SZSE · Healthcare · C 制造业 · CN
CNY 49.50
+0.34%Aug 28, 2026, 10:53 UTC
Yunnan Baiyao proposed a cash dividend of 10.38 yuan per 10 shares (tax inclusive) based on 1.784 billion shares, with no bonus shares or capital reserve conversion.
Source:Aug 28, 2026, 10:53 UTC
Yunnan Baiyao announced its first-half 2026 results: revenue of 21.884 billion yuan, up 2.95% year-on-year, and net profit attributable to shareholders of 3.701 billion yuan, up 1.88% year-on-year.
Source:Aug 11, 2026, 11:09 UTC
Two subsidiaries of Yunnan Baiyao Group were selected as winning bidders in the national Chinese herbal medicine decoction pieces centralized procurement (ZYYPLM-2026-1) and Yunnan Province procurement on August 6, 2026.
Source: